Welcome to the October installment of "FDA News in Review," where each month we look at the agency's latest decision, approvals, warnings and recalls. Over the last few days one of the hottest topics in pharma has been the issue of preemption, which is being argued before the Supreme Court in the case of Wyeth v. Levine. Another important story this month was the FDA's continuing difficulty meeting drug approval deadlines. To get the full scoop on October, check out this report.